I agree that this site is using cookies. You can find further informations here.
X
Brobert, Gunnar
97  results:
Search for persons X
?
1

Comparison of rivaroxaban and low molecular weight heparin ..:

Linder, Marie ; Ekbom, Anders ; Brobert, Gunnar...
Journal of Thrombosis and Thrombolysis.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Comparison of Clinical Outcomes in Patients with Active Can..:

Cohen, Alexander T. ; Wallenhorst, Christopher ; Rivera, Marcella...
Thrombosis and Haemostasis.  , 2024
Link: https://doi.org/10.1055/..
 
?
3

Safety profile of rivaroxaban in first-time users treated f..:

Ruigómez, Ana ; Schink, Tania ; Voss, Annemarie...
PLOS ONE.  19 (2024)  3 - p. e0298596 , 2024
Link: https://doi.org/10.1371/..
 
?
4

Challenges and lessons learned from a long-term postauthori..:

Brobert, Gunnar ; Ruigomez, Ana ; Schink, Tania...
BMJ Open.  14 (2024)  3 - p. e081348 , 2024
Link: https://doi.org/10.1136/..
 
?
5

Effectiveness and Safety of Rivaroxaban and Low Molecular W..:

Coleman, Craig I. ; Caroti, Kimberly Snow ; Abdelgawwad, Khaled...
JACC: CardioOncology.  5 (2023)  2 - p. 189-200 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Time Trends in Patient Characteristics of New Rivaroxaban U..:

Voss, Annemarie ; Smits, Elisabeth ; Swart, Karin M. A....
Drugs - Real World Outcomes.  10 (2023)  2 - p. 215-224 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad..:

Caroti, Kimberly Snow ; Khorana, Alok A. ; Becattini, Cecilia...
Clinical and Applied Thrombosis/Hemostasis.  29 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
8

Safety and effectiveness of rivaroxaban for prevention of s..:

García Rodríguez, Luis Alberto ; Ruigómez, Ana ; Schink, Tania...
Expert Opinion on Drug Safety.  22 (2023)  6 - p. 493-500 , 2023
Link: https://doi.org/10.1080/..
 
?
9

Incidence of hospital-acquired acute kidney injury and traj..:

Ebert, Natalie ; Schneider, Alice ; Huscher, Doerte...
BMC Nephrology.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

Rivaroxaban versus Apixaban for Treatment of Cancer-Associa..:

Caroti, Kimberly Snow ; Becattini, Cecilia ; Carrier, Marc...
TH Open.  7 (2023)  3 - p. e206-e216 , 2023
Link: https://doi.org/10.1055/..
 
?
11

Renal decline in patients with non-valvular atrial fibrilla..:

González Pérez, Antonio ; Balabanova, Yanina ; Sáez, María E...
International Journal of Cardiology.  352 (2022)  - p. 165-171 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Time Trends and Treatment Pathways in Prescribing Individua..:

Vora, Pareen ; Morgan Stewart, Henry ; Russell, Beth...
International Journal of Clinical Practice.  2022 (2022)  - p. 1-9 , 2022
Link: https://doi.org/10.1155/..
 
?
13

CODE-EHR best-practice framework for the use of structured ..:

Kotecha, Dipak ; Asselbergs, Folkert W ; Achenbach, Stephan...
The Lancet Digital Health.  4 (2022)  10 - p. e757-e764 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Safety and effectiveness of appropriately and inappropriate..:

González-Pérez, Antonio ; Roberts, Luke ; Vora, Pareen...
BMJ Open.  12 (2022)  6 - p. e059311 , 2022
Link: https://doi.org/10.1136/..
 
?
15

CODE-EHR best practice framework for the use of structured ..:

Kotecha, Dipak ; Asselbergs, Folkert W ; Achenbach, Stephan...
European Heart Journal.  43 (2022)  37 - p. 3578-3588 , 2022
Link: https://doi.org/10.1093/..
 
1-15